BCWORLD PHARM. Co. Ltd Total Liabilities

Latest as of September 2025: ₩101.30 Billion KRW ≈ $68.65 Million USD

BCWORLD PHARM. Co. Ltd total liabilities. Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has total liabilities worth ₩101.30 Billion KRW (≈ $68.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BCWORLD PHARM. Co. Ltd (200780) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of BCWORLD PHARM. Co. Ltd (2015–2024)

Total liabilities of BCWORLD PHARM. Co. Ltd from 2015 to 2024. This chart illustrates how BCWORLD PHARM. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 200780 long-term investment intensity to see how much of total assets are deployed in long-term investments.

BCWORLD PHARM. Co. Ltd Competitors by Total Liabilities

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Integral Acquisition 1 Corp NASDAQ:INTE	USA	$5.10 Million
Tai Twun Enterprise Co Ltd TW:3432	Taiwan	NT$75.69 Million
Spacenet Enterprises India Limited NSE:SPCENET	India	Rs496.11 Million
Wescoal Holdings Ltd JSE:SLG	South Africa	ZAC4.45 Billion
Jacques Bogart SA PA:JBOG	France	€291.72 Million
Hannet Co. Ltd KQ:052600	Korea	₩23.59 Billion
Huddlestock Fintech As OL:HUDL	Norway	Nkr47.79 Million
Matricelf Ltd TA:MTLF	Israel	ILA2.70K

Liability Composition Analysis (2015–2024)

This chart breaks down BCWORLD PHARM. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BCWORLD PHARM. Co. Ltd total assets.

Liquidity & Leverage Metrics

BCWORLD PHARM. Co. Ltd Total Liabilities Ratios Explained

BCWORLD PHARM. Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BCWORLD PHARM. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual total liabilities of BCWORLD PHARM. Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩99.65 Billion ≈ $67.53 Million	-2.75%
2023-12-31	₩102.47 Billion ≈ $69.44 Million	-1.00%
2022-12-31	₩103.50 Billion ≈ $70.14 Million	+5.72%
2021-12-31	₩97.90 Billion ≈ $66.35 Million	+7.27%
2020-12-31	₩91.27 Billion ≈ $61.85 Million	+20.83%
2019-12-31	₩75.53 Billion ≈ $51.19 Million	+5.42%
2018-12-31	₩71.65 Billion ≈ $48.56 Million	+93.06%
2017-12-31	₩37.11 Billion ≈ $25.15 Million	+64.62%
2016-12-31	₩22.54 Billion ≈ $15.28 Million	+88.58%
2015-12-31	₩11.96 Billion ≈ $8.10 Million	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$19.40 Million

₩28.63 Billion KRW

Market Cap Rank

#25052 Global

#1831 in Korea

Share Price

₩2800.00

Change (1 day)

-0.36%

52-Week Range

₩2790.00 - ₩5870.00

All Time High

₩30700.49